Delivery Order SPE2DR25D3202-SPE2DR26F8E3F
- Not listed
- The Defense Logistics Agency awarded a $2,271.36 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of YONSA 125 mg tablets (120 count). This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, is to be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation and represents a child contract under AmerisourceBergen's larger federal...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of YONSA 125 mg tablets (120-count units) with a ceiling value of $2,271.36 and a firm fixed price structure. This non-set-aside delivery order is scheduled for completion by September 29, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order issued...
- The Defense Logistics Agency awarded a $2,393.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for YONSA 125 mg tablets (120-count supply) with an ultimate completion date of January 21, 2026. This non-set-aside award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- AmerisourceBergen Drug Corp received a $2,271.36 delivery order from the Defense Logistics Agency (DLA) on May 13, 2025, for the supply of YONSA 125 mg tablets (120-count units). The contract is classified as a firm fixed price delivery order with an ultimate completion date of June 4, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award represents a non-set-aside procurement awarded through competitive means, consistent with...
- The Defense Logistics Agency awarded a delivery order valued at $2,393.67 to AmerisourceBergen Drug Corp for 120 tablets of Yonsa 125 mg on December 23, 2025, with completion expected by January 15, 2026. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement executed under AmerisourceBergen's existing contract vehicle with DLA. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,271.36 for 120 tablets of YONSA 125 mg on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price, competitively awarded contract required no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a $2,271.36 delivery order to AmerisourceBergen Drug Corp for 120 tablets of YONSA 125 mg, a pharmaceutical product to support federal medical procurement needs. This competitive, non-set-aside award was issued on October 23, 2025, with an ultimate completion date of November 14, 2025. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under a firm fixed-price contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,271.36 to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Yonsa 125 mg tablets (120-count units). This is a firm fixed-price delivery order with an ultimate completion date of June 11, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This...
- The Defense Logistics Agency awarded a $2,271.36 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Yonsa 125 mg tablets (120 count). The contract is a firm fixed-price delivery order with a completion date of September 17, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on December 11, 2025, for the supply of Yonsa 125 mg tablets (120-count units) with a ceiling value of $4,787.34. This is a firm fixed-price delivery order with an ultimate completion date of January 5, 2026. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet...
- SPE2DR25D3202Indefinite Delivery Contract
- SPE2DR25D3202-SPE2DR26F8E3FDelivery Order
The Defense Logistics Agency awarded a $2,393.67 delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of YONSA 125 mg tablets (120-count packaging), with an ultimate completion date of January 26, 2026. This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999.00 and extends through December 2026. This comprehensive prime vendor contract enables the company to supply an extensive portfolio of pharmaceutical products and medical supplies to support military healthcare programs globally, including support for the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's federal contract portfolio demonstrates its critical role as a major pharmaceutical distributor within the federal medical procurement system, consistently delivering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains through competitively awarded contracts with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 1/1/26 |